Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series

Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series

OBJECTIVES:. A recent study suggests that Multisystem Inflammatory Syndrome in Children (MIS-C) is triggered by gastrointestinal breach of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral particles from the gut lumen into systemic circulation. The virus remains in the gut weeks to...

Full description

Bibliographic Details
Main Authors: Lael M. Yonker, MD, Zoe Swank, PhD, Tal Gilboa, PhD, Yasmeen Senussi, MBBS, Victoria Kenyon, BA, Lena Papadakis, BS, Brittany P. Boribong, PhD, Ryan W. Carroll, MD, MPH, David R. Walt, PhD, Alessio Fasano, MD
Format: Article
Language:English
Published: Wolters Kluwer 2022-02-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000000641

Internet

http://journals.lww.com/10.1097/CCE.0000000000000641

Similar Items